The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-Chloro-3'-fluoro-5-methoxy-[1,1'-biphenyl]-4-yl)-N-(isoxazol-3-yl)-3-oxo-2,3-dihydroisoquinoline-6-sulfonamide ID: ALA4068143
PubChem CID: 117753939
Max Phase: Preclinical
Molecular Formula: C25H17ClFN3O5S
Molecular Weight: 525.95
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(-c2cccc(F)c2)c(Cl)cc1-c1[nH]c(=O)cc2cc(S(=O)(=O)Nc3ccon3)ccc12
Standard InChI: InChI=1S/C25H17ClFN3O5S/c1-34-22-13-19(14-3-2-4-16(27)9-14)21(26)12-20(22)25-18-6-5-17(10-15(18)11-24(31)28-25)36(32,33)30-23-7-8-35-29-23/h2-13H,1H3,(H,28,31)(H,29,30)
Standard InChI Key: IJKKZVFOENDHPB-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
32.0345 -14.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9125 -14.3566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9660 -13.0758 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7328 -13.5174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1444 -13.5081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7479 -15.9712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1145 -11.0566 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.8479 -13.0938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9006 -13.5353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3033 -13.8199 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9679 -11.1273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2146 -15.5785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9210 -15.9831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0078 -12.2973 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
33.4241 -12.2904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7791 -13.1558 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.6240 -15.5713 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.3158 -13.5301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4368 -13.1024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3251 -14.3410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1247 -11.8738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6205 -14.7550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0170 -13.1144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3197 -12.2797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.1667 -10.9664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7661 -11.6787 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.2095 -14.7683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0596 -11.9377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7718 -12.3383 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0383 -15.5659 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.4932 -13.5561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4970 -14.3726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8410 -12.2758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1887 -13.1384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7386 -14.3354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9250 -16.8002 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16 31 1 0
3 16 2 0
23 14 1 0
24 28 2 0
20 1 2 0
33 21 1 0
23 18 2 0
1 35 1 0
28 11 1 0
2 27 1 0
9 34 2 0
22 20 1 0
2 9 1 0
4 19 1 0
31 32 2 0
17 22 1 0
8 33 2 0
21 15 2 0
32 27 1 0
30 6 1 0
18 20 1 0
26 24 1 0
19 5 2 0
13 17 1 0
1 30 1 0
34 31 1 0
2 22 2 0
4 23 1 0
28 29 1 0
16 10 2 0
12 13 1 0
25 26 1 0
11 25 2 0
21 7 1 0
5 8 1 0
29 16 1 0
27 12 2 0
35 4 2 0
15 19 1 0
13 36 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 525.95Molecular Weight (Monoisotopic): 525.0561AlogP: 5.45#Rotatable Bonds: 6Polar Surface Area: 114.29Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.44CX Basic pKa: ┄CX LogP: 3.09CX LogD: 2.39Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.30Np Likeness Score: -1.18
References 1. Weiss MM, Dineen TA, Marx IE, Altmann S, Boezio A, Bregman H, Chu-Moyer M, DiMauro EF, Feric Bojic E, Foti RS, Gao H, Graceffa R, Gunaydin H, Guzman-Perez A, Huang H, Huang L, Jarosh M, Kornecook T, Kreiman CR, Ligutti J, La DS, Lin MJ, Liu D, Moyer BD, Nguyen HN, Peterson EA, Rose PE, Taborn K, Youngblood BD, Yu V, Fremeau RT.. (2017) Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities., 60 (14): [PMID:28287723 ] [10.1021/acs.jmedchem.6b01851 ]